Home » New Label Says Tysabri Risks Increase Over Time
New Label Says Tysabri Risks Increase Over Time
A brain infection linked to Biogen Idec Inc. and Elan Corp.’s Tysabri is more likely
to occur the longer patients use the multiple sclerosis drug, new prescribing information says.
boston
boston
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May